Literature DB >> 10741392

Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level.

C Giuliani1, G Napolitano, A Mastino, S Di Vincenzo, C D'Agostini, S Grelli, I Bucci, D S Singer, L D Kohn, F Monaco, E Garaci, C Favalli.   

Abstract

In this study we examined the effect of the synthetic peptide thymosin-alpha1 (T(alpha)1) on MHC class I expression in FRTL-5 cells. Treatment with T(alpha)1 increased expression of MHC class I surface molecules and mRNA, which reached its peak (153 +/- 8 % of the control value) after 12 h. Chloramphenicol acetyltransferase (CAT) analysis, following transfection with a plasmid containing the regulatory sequence of MHC class I (or its deletion derivatives) with the CAT reporter gene, and electrophoretic mobility shift assay experiments demonstrated that the action of T(alpha)1 was at the transcriptional level, and its mechanism of action is likely due to increased binding between the complex p50/fra-2 and the enhancer A sequence of the 5' flanking region of a swine class I gene (PD1). An increase in the expression of MHC class I surface molecules was also observed by flow cytometry in murine and human tumor cell lines and in primary cultures of human macrophages. This study shows for the first time an effect of Talpha1 on the regulation of gene expression at the molecular level, and may further contribute to explaining the results obtained using Talpha1 in the control of infectious diseases and tumor growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10741392     DOI: 10.1002/1521-4141(200003)30:3<778::AID-IMMU778>3.0.CO;2-I

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy.

Authors:  D Chadwick; J Pido-Lopez; A Pires; N Imami; F Gotch; J S Villacian; S Ravindran; N I Paton
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

2.  Advances in the Treatment of Hepatitis B and Hepatitis C Nonresponders: A Report of Symposia Presented at the 15th Conference of the Asian Pacific Association for the Study of the LiverAugust 18-21, 2005Bali, Indonesia.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

3.  Thymosin alpha 1: biological activities, applications and genetic engineering production.

Authors:  Juan Li; Chun Hui Liu; Feng Shan Wang
Journal:  Peptides       Date:  2010-08-10       Impact factor: 3.750

4.  Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients.

Authors:  Claudia Matteucci; Antonella Minutolo; Emanuela Balestrieri; Vita Petrone; Marialaura Fanelli; Vincenzo Malagnino; Marco Ianetta; Alessandro Giovinazzo; Filippo Barreca; Silvia Di Cesare; Patrizia De Marco; Martino Tony Miele; Nicola Toschi; Antonio Mastino; Paola Sinibaldi Vallebona; Sergio Bernardini; Paola Rogliani; Loredana Sarmati; Massimo Andreoni; Sandro Grelli; Enrico Garaci
Journal:  Open Forum Infect Dis       Date:  2020-12-05       Impact factor: 3.835

5.  Hormonal Regulation of the MHC Class I Gene in Thyroid Cells: Role of the Promoter "Tissue-Specific" Region.

Authors:  Cesidio Giuliani; Sara Verrocchio; Fabio Verginelli; Ines Bucci; Antonino Grassadonia; Giorgio Napolitano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-06       Impact factor: 5.555

6.  The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations.

Authors:  Yongdong Feng; Guangkuo Zhu; Song Lang; Ping Hao; Guanghui Li; Fanglin Chen; Wenlei Zhuo; Yuzhong Duan; Anmei Zhang; Zhengtang Chen; Jianguo Sun
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 6.244

7.  Expression and hydroxylamine cleavage of thymosin alpha 1 concatemer.

Authors:  Liang Zhou; Zong-Teng Lai; Min-Kan Lu; Xing-Guo Gong; Yi Xie
Journal:  J Biomed Biotechnol       Date:  2008

8.  Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK.

Authors:  Walter Mandaliti; Ridvan Nepravishta; Francesca Pica; Paola Sinibaldi Vallebona; Enrico Garaci; Maurizio Paci
Journal:  Molecules       Date:  2017-10-27       Impact factor: 4.411

Review 9.  The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer.

Authors:  Cesidio Giuliani; Ines Bucci; Giorgio Napolitano
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-21       Impact factor: 5.555

10.  Thymosin α1 protects from CTLA-4 intestinal immunopathology.

Authors:  Giorgia Renga; Marina M Bellet; Marilena Pariano; Marco Gargaro; Claudia Stincardini; Fiorella D'Onofrio; Paolo Mosci; Stefano Brancorsini; Andrea Bartoli; Allan L Goldstein; Enrico Garaci; Luigina Romani; Claudio Costantini
Journal:  Life Sci Alliance       Date:  2020-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.